RecruitingNCT06231563
Ketamine or active placebo for depression in veterans with Parkinson’s disease
About this title
Read the official source — NCT06231563Researchers are comparing ketamine and placebo to find out how the approaches affect depression symptoms in veterans with depression.
Medication studyAges 40–80United States
Understand this study
What is this study about?
Researchers are comparing ketamine and placebo to find out how the approaches affect depression symptoms in veterans with depression.
Who could participate?
Listed age limits: 40 years to 80 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 1, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 40 Years to 80 Years
- Official registry ID
- NCT06231563
- Official title
Show the full official title
Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Francisco
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing ketamine and placebo to find out how the approaches affect depression symptoms in veterans with depression.
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including ketamine and Remimazolam.
Who can participate?
Listed age limits: 40 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
